A perivascular system releasing sirolimus prevented intimal hyperplasia in a rabbit model in a medium-term study  by Skalský, Ivo et al.
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The  main  complication  of aortocoronary  reconstruction  with  vein  grafts  is  restenosis  in  the course  of
time.  The  aim  was  to assess  the  effect  of  a periadventitial  polyester  mesh  releasing  sirolimus  on  intimal
hyperplasia  of  autologous  grafts.  We  implanted  v.  jugularis  ext. into  a.  carotis  communis  in rabbits.  The
vein  graft  was  either  intact,  or was  wrapped  with  a pure  polyester  mesh,  or with  a sirolimus-releasing
mesh.  Three  and  six  weeks  after  surgery,  the veins  were  subjected  to standard  histological  staining
and  the thicknesses  of  the  tunica  intima,  the  media  and  the  intima–media  complex  were  measured.
Wrapping  the  vein  with  a mesh  releasing  sirolimus  or with  a pure  mesh  decreased  the  thickness  of theerivascular wrap
ontrolled  drug release
utologous  vein
ntimal  hyperplasia
intima  in  comparison  with  a vein  graft  by  73  ± 11% or 73  ±  8%  after  3 weeks,  and  by  73 ± 9% or  59 ±  12%
after  6  weeks,  respectively.  Sirolimus-releasing  meshes  reduced  the  thickness  of  the  media  by 65 ± 9%
and  20  ±  12%  after  3 and  6  weeks.  The  thickness  of the  intima–media  complex  in  grafts  with  sirolimus-
releasing  meshes  decreased  by  60 ± 6% and  30  ±  13%  in comparison  with  pure  PES  meshes,  after  3 and
6  weeks,  respectively.  A  periadventitial  polyester  mesh  releasing  sirolimus  has  the  potential  to  become
an  effective  device  in preventing  vein  graft  restenosis.. Introduction
Occlusion of the graft lumen is considered as the main com-
lication in the follow-up of patients after aortocoronary vein
ypass grafting. This occurs almost in 15% within the ﬁrst year, and
ncreases up to 50% of occluded veins after 10 years (Motwani and
opol, 1998). In patent vein grafts, 7% show signs of degeneration
fter 1 year and 77% after 10 years (Fitzgibbon et al., 1996).
Due to a mechanical mismatch after implantation, an autol-
gous vein graft in arterial circulation is prone to remodelling.
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This is accompanied by excessive proliferation of vascular smooth
muscle cells (VSMC), which can migrate into the intima and pro-
duce extracellular matrix. Graft remodelling thus results in intimal
hyperplasia and graft stenosis. In clinical practice, autologous graft
stenosis is usually dealt with (after percutaneous transluminal
angioplasty) by inserting stents, often loaded with antiprolifer-
ative drugs, e.g. sirolimus-eluting stents (CypherTM, Cordis J&J,
NJ), or paclitaxel-eluting stents, into the graft lumen (Colombo
and Iakovou, 2004). However, the use of stents is limited by the
relatively complicated process for inserting them, by increased
mechanical strain on the vessel wall, and by local damage to the
endothelium and VSMC leading to reactivation of VSMC growth
and restenosis of the vessel. In addition, the stents can be released
and can move inside the vessel (Jeremy et al., 2004). Similar prob-
lems are associated with drug-releasing polymeric ﬁlms covering
the luminal surface of a vessel, e.g. hydrogel ﬁlms loaded with
paclitaxel (Livnat et al., 2005).
Open access under CC BY-NC-ND license.From this point of view, an external drug delivering system,
i.e. placed on the adventitial surface of the vascular graft, seems
to be more advantageous. Periadventitial delivery of heparin from
matrices placed adjacent to rat carotid arteries was  successfully
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sed in the case of heparin, which is well known to attenuate
roliferation of VSMC (Edelman et al., 1990). Other antiprolifer-
tive drugs have also been found to inhibit neointimal hyperplasia
f vein grafts in animal experimental models after local extralumi-
al application, for example suramin, C-type natriuretic peptide,
ilostazol, and sirolimus (Schachner et al., 2004a,b; Hu et al.,
999; Fujinaga et al., 2004). Especially sirolimus (Rapamycin) is
 drug well known for its potent antiproliferative action. In addi-
ion to its application in drug-eluting stents (Colombo and Iakovou,
004), this macrocyclic lactone has also been used clinically for
mmunosuppressive therapy after organ transplantation (Roque
t al., 2001). The mechanism of its antiproliferative effect is very
omplex (Yakupoglu and Kahan, 2003; Regar et al., 2001), involv-
ng mainly blocking the transition from the G1 phase to the S phase
f the cell cycle by interacting with a speciﬁc target protein (mTOR,
ammalian target of sirolimus) and inhibiting its activation. Our
arlier study focused on the kinetics of the release of sirolimus
rom polyester meshes in vitro (Filova et al., 2011). In these experi-
ents, the release of sirolimus from polyester meshes coated with
 degradable copolymer loaded with sirolimus was  detected for
everal weeks. The proliferation of VSMC in culture plates was
nhibited if sirolimus-releasing meshes were used. For the present
tudy, we assumed that the graft wall of the vessel would be thin
nough to enable diffusion of sirolimus released from a periadventi-
ially placed mesh into the tunica media, so that VSMC proliferation
ould be inhibited.
It has been suggested that thickening of the intima of the vein
rafts increased in the distended regions, where the grafts were
ubjected to low ﬂow velocity (Dobrin, 1995). Thus, we expected
hat in addition to the antiproliferative effects of sirolimus, our
eshes would also reduce the risk of graft restenosis by minimiz-
ng distension of the graft. From this point of view, encouraging
esults were obtained in an in vivo study performed on sheep.
heathing the implanted vein grafts with a pressure-resistant
olyester (torlen/dacron) mesh signiﬁcantly reduced intima thick-
ning in these grafts compared to control untreated vein grafts
ithin 12 weeks after implantation (Krejca et al., 2002). Taken
ogether, the mesh placed around the graft should serve as a
echanical support for the graft wall, which increases the resis-
ance of the graft against high pressure, decreases tangential stress
nd retards graft degeneration (Jeremy et al., 2004; Krejca et al.,
002).
We therefore developed a novel combined device composed
f two synergistically effective components: a mechanically sup-
ortive polyester mesh, and an antiproliferative drug (sirolimus).
ur work extended previous preliminary study about early inti-
al  changes in the autologous vein grafts (Skalsky et al., 2011).
e evaluated the dynamics of the vascular wall changes during a
edium-term examination in vein grafts in rabbits, wrapped with a
irolimus-releasing polyester mesh. Sustained release of sirolimus
ithin a period of several weeks suppressed VSMC proliferation
or the time necessary for re-endothelialization of the graft. These
ffects reduced autologous graft remodelling and the need for sub-
equent treatment.
. Materials and methods
.1. Materials
Polyester mesh (CHS 50, PES mesh) was obtained from VUP
oint-Stock Co., Brno, CR. Purasorb PLC 7015, and a grade copolymer
f l-lactide and -caprolactone (70/30 molar ratio, inherent viscos-
ty midpoint of 1.5 dl/g) was purchased from PURAC biomaterials.
irolimus (Rapamycin from Streptomyces hygroscopicus, Cat. No.
0395) was obtained from Sigma–Aldrich (Germany).harmaceutics 427 (2012) 311– 319
2.2. Mesh impregnation
Polyester mesh impregnation was  described in a previous paper
(Filova et al., 2011). Brieﬂy, the mesh was coated with a solution
containing 5.2 mg  of sirolimus and 36.4 mg  of purasorb in 1 ml of
chlorobenzene–ethanol (1.75:1, v/v). It was  dried, and then coated
for a second time with the same solution and dried again. Finally,
the impregnated mesh contained 0.14 mg  of sirolimus per cm2. The
mesh was  dried out in a vacuum oven for 3 weeks, and was then
sterilized with ethylene oxide (sirolimus-releasing PES mesh).
2.3. Implantation procedures
The experiments on laboratory animals were approved by the
Authorization No. 48/2009 issued by the Chief Hygienist of the
Czech Republic, the Ministry of Health of the Czech Republic
according to the law No. 246/1992 of the Collection and in compli-
ance with further regulations, for the protection of animals against
suffering, and in accordance with the Project of Experiments and
the statement of the Ethical Committee. Male Giant Chinchilla
rabbits (3.0–3.5 kg; n = 65; Table 1) were anaesthetized using an
intramuscular injection of ketamine hydrochloride (30.0 mg/kg).
Anaesthesia was maintained with isoﬂurane (2.5–3.0%), inhaled
through a mask. Heparin (300 IU/kg) was  given intravenously to
the animals. The operative procedure was  performed with an asep-
tic technique with operating glasses (magniﬁcation 2.5×). The
right external jugular vein and the right common carotid artery
were exposed through a vertical midline cervical incision. The vein
bypass grafts were constructed using an anastomotic cuff technique
(Jiang et al., 2004) (Fig. 1).
A segment of the external jugular vein approximately 2 cm in
length was harvested for an autologous reversed-vein graft; the
segments were also used as the graft 0 control group. The polymer
cuffs were prepared from a 4F endovascular catheter (Terumo Med-
ical Corp, Elkton, MD). The jugular vein ends were passed through a
cuff, everted, and ﬁxed using 8-0 monoﬁlament polypropylene silk.
The common carotid artery was  clamped distally and proximally,
and the lumen was  then exposed using a small arteriotomy, and the
cuffed, reversed vein ends were inserted. A second 8-0 polypropy-
lene silk was  used to ligature (i.e. secure) the artery around the cuff
on both sides. The back wall of the carotid artery between the cuffs
was excised to allow a vein graft extension (an untreated autolo-
gous graft). Finally, a pure PES mesh or a sirolimus-releasing PES
mesh was  put on around the vein graft and ﬁxed by polypropy-
lene 8/0 on the side (autologous graft wrapped with a PES mesh,
an autologous graft wrapped with sirolimus-releasing PES mesh)
(Jiang et al., 2004).
Groups of animals were euthanized 3 and 6 weeks after implan-
tation. The specimens were equally divided in the middle of the vein
graft (without the cuff segment) to obtain equal parts for histology
and for immunohistochemistry.
2.4. Histology and immunohistochemistry
The venous grafts were divided into two parts. One  part was
ﬁxed in 10% formalin and then it was embedded in parafﬁn. The
second part was embedded in Sakura Finetek Tissue Tek© Cryomold
holders and Sakura Finetek Tissue Tek© OCT Compound (both from
Sakura Finetek, Tokyo, Japan). The samples were subsequently
frozen in 2-methylbutane (Fluka Chemika, Buchs, Switzerland)
cooled by liquid nitrogen, and then stored at −80 ◦C.2.5. Histological analysis
The samples embedded in parafﬁn were cut into 3–4 m
sections and stained with haematoxylin-eosin, Van Gieson with
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Table 1
Number of CD4+ cells, CD8+ cells, plasmocytes, macrophages and Fe particles in transverse histological sections through untreated autologous grafts (Graft), grafts wrapped
with  a pure PES mesh (PES mesh) or with a sirolimus-releasing PES mesh (Sirolimus) 3 and 6 weeks (3w, 6w)  after implantation. Mean ± SEM from 7 to 10 rabbits (10
microscopic ﬁelds per animal). Olympus BX41 microscope, magniﬁcation 600×, numbers of rabbits with any kind of thrombus, with oblitering or recanalized thrombi are
also  given. Non-parametric Kruskal–Wallis one-way analysis of variance (ANOVA) was used.
1. Graft 0w 2. Graft 3w 3. PES mesh 3w 4. Sirolimus 3w 5. Graft 6w 6. PES mesh 6w 7. Sirolimus 6w
No of animals 12 7 9 9 10 8 10
CD4+
# vs. 2
** vs. 3
# vs. 1
# vs. 4
**vs. 1
* vs. 4
# vs.2
*vs. 3
1.1 ± 0.4 50.7 ± 19.9 30.0 ± 2.6 0.6 ± 0.4 10.7 ± 1.1 12.8 ± 4.5 12.8 ± 3.8
CD8+
** vs. 3
# vs. 2, 6
# vs. 1 # vs. 5, 7
**vs. 1, 4
** vs.3 # vs. 3 # vs. 1 # vs. 3
0.6  ± 0.2 27.5 ± 17.3 17.0 ± 2.4 0.8 ± 0.4 2.9 ± 0.3 10.0 ± 3.4 1.8 ± 0.5
Plasmocytes
** vs. 5 * vs. 5 *vs. 4, # vs.7 ** vs. 1 # vs. 5
0  ± 0 4.6 ± 1.8 3.2 ± 1.6 0 ± 0 6.9 ± 2.0 2.5 ± 0.7 0.4 ± 0.4
Macrophages
** vs. 7 * vs. 7 ** vs. 1 * vs. 4
0  ± 0 1.6 ± 1.1 5.7 ± 4.0 0 ± 0 2.8 ± 1.3 1.2 ± 0.6 13.2 ± 9.6
Fe  particles
* vs. 5 # vs. 5 * vs. 5 * vs. 5 * vs. 1, 3, 4, 7# vs. 2 *vs. 5
0  ± 0 0 ± 0 0 ± 0 0 ± 0 120.8 ± 79.1 5.1 ± 5.1 0 ± 0
Rabbits with any
kind/oblitering/
recanalized thrombus
0/0/0 3/0/1 5/1/3 5/0/1 5/3/0 5/1/2 3/0/0
cal sig
cal sig
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w# p < 0.05 in comparison with the sample labelled with the same number (statisti
* p < 0.01 in comparison with the sample labelled with the same number (statisti
** p < 0.001 in comparison with the sample labelled with the same number (statis
lastica, von Kossa and Pearl’s stains. The sections were taken from
he midportion of the graft to avoid tissue that may  have reacted
o the suture material. Each section stained with Van Gieson with
lastica was photographed using an Olympus IX 51 microscope and
 DP 70 digital camera.
.6. Immunohistochemical staining
Information concerning the primary antibodies used for the
mmunohistochemical analyses is shown in Table 2..6.1. Formol ﬁxed, parafﬁn embedded tissues
Immunohistochemistry was performed on 4 m-thick paraf-
n sections using a three-step indirect method. The slides were
eparafﬁnized in xylene and rehydrated in graded ethanol. After
ig. 1. Scheme of the surgical technique for graft implantation (A), the autologous vein b
ith  a PES mesh (D).niﬁcance).
niﬁcance).
igniﬁcance).
deparafﬁnization and rehydration, the slides were cooked in a
microwave oven using 0.01 M citrate buffer pH 6.0 (detection
of smooth muscle actin), or EDTA buffer pH 8.0 (detection of
PCNA) for target retrieval, or proteinase K was applied (detection
of macrophages and CD31). Endogenous peroxidase was blocked
by 0.3% H2O2 in 70% methanol for 30 min. Endogenous biotin
was blocked with the biotin-blocking system (Dako, Glostrup,
Denmark). The tissues were then preincubated with a 10% horse
serum (Vector laboratories, Burlingame, CA) for 20 min  to prevent
nonspeciﬁc binding and FcR binding. The primary antibody was
applied for 30 min  RT or incubated overnight at 4 ◦C (CD31). Detec-
tion of the monoclonal antibody was performed using biotinylated
horse anti-mouse IgG (Vector laboratories, Burlingame, CA, USA)
diluted 200× for 30 min. The specimens were then incubated with
RTU Vectastain Elite ABC Reagent for 30 min. Finally, the specimens
efore a clip release (B), the dilated vein graft (C) and the dilated vein graft wrapped
314 I. Skalsky´  et al. / International Journal of Pharmaceutics 427 (2012) 311– 319
Table  2
The list of monoclonal antibodies used for immunohistochemical staining.
Speciﬁcity Origin Company Dilution Clone
CD4+ cells Mouse Novus Biological, CO, USA 50× KEN-4
CD8+  cells Mouse LifeSpan Biosciences, WA,  USA 100× NA
-Smooth muscle actin Mouse Sigma, MO, USA 900× 1A4
, UK 
, UK 
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CD31 Mouse Abcam
PCNA Mouse Dako,
ere stained with Dako Liquid DAB+ Substrate-Chromogen Sys-
em (Dako, Glostrup, Denmark) for 5 min, and were counterstained
ith Harris’s haematoxylin before they were embedded in Entellan
both from Merck, Germany).
.6.2. Snap-frozen tissue samples
Immunohistochemistry was performed on sections 8 m in
hickness, using a three-step indirect method. The sections were
xed for 10 min  in cold acetone. Following this, the sections were
insed in 0.2% Triton X-100 and phosphate-buffered saline, and
ndogenous biotin was blocked with a biotin-blocking system
Dako, Glostrup, Denmark). The tissues were then incubated in 10%
orse serum, after which a primary antibody (anti-CD4/CD8) was
pplied for 60 min. In addition, endogenous peroxidase was  blocked
n 0.3% H2O2 and 70% methanol for 30 min. The specimen was
ncubated with a secondary biotinylated horse anti-mouse anti-
ody (Vector Lab, Burlingame, CA, USA), followed by incubation
ith RTU Vectastain Elite ABC Reagent (Vector Lab, Burlingame,
A, USA). Finally, the specimens were incubated for 5 min  with the
ako Liquid DAB+ Substrate-Chromogen System (Dako, Glostrup,
enmark), counterstained with Harris’s haematoxylin and embed-
ed in Entellan (both from Merck, Germany).
The total numbers of CD4+ cells, CD8+ cells, neutrophils, plasmo-
ytes, eosinophils, macrophages, foreign body giant cells, Fe and Ca
articles were counted in the entire cross-section of the vein grafts
n 10 microscopic ﬁelds per rabbit at magniﬁcation 600×.
.7. Thickness of intima, media, media–intima complex,
edia–intima ratio
The following parameters were measured: the thickness of the
ntima from the endothelial surface to the inner border of the tunica
edia, the thickness of the media from the inner border of tunica
edia to the border between tunica media and adventitia, and the
hickness of the media–intima complex from the endothelial sur-
ace to the media–adventitia border. Data was collected from 32
o 84 measurements per rabbit in 12–28 microscopic ﬁelds, using
he MeasureStackLines plug-in module of Ellipse Software (ViDiTo
ystems, Slovakia). The media/intima ratio was calculated from the
easured values. The mean value and the Standard Error of Mean
mean ± SEM) were calculated for each vein and for each animal
roup. Grafts with thrombosis were not measured.
.8. Statistical methods
Non-parametrical one-way Kruskal–Wallis ANOVA was used
or a statistical evaluation of the histology and histomorphome-
ry. Two-way ANOVA and the Tukey studentized range method
ere used for the data analyses of the thickness of the intima,
edia, intima/media complex and the media/intima ratio. The vari-bles were tested for normality by Shapiro and Wilk’s statistics.
ince normality was rejected, the logarithmic transformation was
pplied. The effects of time, drug, and the interaction between time
nd drug were tested, and p < 0.05 was considered to be signiﬁcant.200× MAC387
20× JC/70A
ark 6000× PC 10
3. Results
3.1. Histology and immunohistochemical staining
3.1.1. Tunica intima
In all experimental groups of animals, the luminal surface
of the venous graft was covered by a layer of endothelial cells
(Figs. 2 and 3). In some grafts, thrombi were observed on the
luminal surface of tunica intima (Table 1). Some thrombi entirely
obliterated the graft lumen, while others were only parietal or
recanalized, but no signiﬁcant differences were found among the
rabbit groups. However, there was  a signiﬁcant difference in the
thickness of the intima among the samples (see also below in
Section 3.3). Focally, smooth muscle cells were observed in the
neointima, especially in samples from animals without the appli-
cation of sirolimus.
3.1.2. Tunica media
In all groups, the adaptation process of vein grafts to arterial
pressure led to the formation of multiple smooth muscle cells lay-
ers, which resulted in thickening of the media (Fig. 3; see also
below in Section 3.3). This was  accompanied by an increased num-
ber of PCNA+ cells (Fig. 2; see also below in Section 3.2). In the
venous autograft with the sirolimus-releasing mesh, the inﬁltra-
tion of CD4+ and CD8+ cells was remarkably decreased in the vessel
wall (i.e. complex of intima, media and adventitia) compared to the
untreated autologous graft and the graft wrapped with a PES mesh
after 3 weeks (Table 1, Fig. 4).
The number of plasmocytes and macrophages was very small in
all groups. There were only sporadic neutrophils and eosinophils in
the venous grafts (data not shown). After 6 weeks, a lower number
of plasmocytes was  found in veins with a sirolimus-releasing mesh
compared to the untreated autologous graft. However, in veins with
a sirolimus-releasing mesh, the number of macrophages increased
signiﬁcantly between the 3rd week and the 6th week, although
they were similar in number to those in both control groups after
6 weeks (Table 1). No calcium particles were found in any of the
groups. No infectious wound complications were observed in any
of the groups of animals. One rabbit died during the operation, and
two rabbits due to systemic infection.
3.1.3. Tunica adventicia
Histological staining revealed the presence of PES meshes and
sirolimus-releasing PES meshes in the adventitia of the vein grafts.
In all groups, the distribution of immunocompetent cells, i.e. plas-
mocytes, CD4+ and CD8+ cells, was  similar to the distribution of
these cells in the tunica media (Fig. 4A), see Section 3.1.2 (Table 1).
Small deposits of iron were sometimes observed, probably as a his-
tological correlate of haematoma resorption (Fig. 4B). In addition,
in groups with a PES mesh and a sirolimus-releasing PES mesh,
foreign-body giant cells were observed around the meshes (Fig. 4C
and D).
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Fig. 2. Immunohistochemical staining of CD31 (A–C) and proliferating cell nuclear antigen (PCNA, D–F) in an untreated autologous graft (A, D), an autologous graft wrapped
w  mesh
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sith  a PES mesh (B, E), an autologous graft wrapped with a sirolimus-releasing PES
agniﬁcation 400×, positively stained cells are brown. (For interpretation of the re
rticle.)
.2. Proliferating cell nuclear antigen (PCNA)
Most of the PCNA+ cells were found in the media and intima
Figs. 2 and 5), and fewer in the adventitia. The highest number of
CNA+ cells was observed in the control untreated grafts 3 weeks
fter implantation (graft 3w). After 3 weeks, wrapping the vein
raft with a pure PES mesh reduced the number of PCNA+ cells
y 59 ± 15%, while wrapping with sirolimus-releasing PES meshes
educed the number by 84 ± 13%. After 6 weeks, the number of
CNA+ cells decreased signiﬁcantly in the control untreated graft
graft 6w); however, the number did not change in grafts wrapped
ith a pure PES mesh or with a sirolimus-releasing mesh.
.3. Thickness of the intima, media, media–intima complex, and
he media/intima ratioThe intima measurements (Fig. 6A) after 3 weeks showed the
ighest intima thickness value in the control graft. In grafts
rapped with a PES mesh or with a sirolimus-releasing mesh,
ig. 3. An autologous vein graft A, D), an autologous vein graft wrapped with a polyester
irolimus (C, F) after 3 (A–C) and 6 weeks (D–F) in rabbits, van Gieson and elastica staining (C, F) 3 weeks after implantation into rabbits, Olympus BX41 microscope original
ces to colour in this ﬁgure legend, the reader is referred to the web version of this
the thickness of the intima was  reduced by 73 ± 8% and 73 ± 11%,
respectively, compared to the untreated graft.
Between the 3rd and 6th weeks, the intimal thickness of the
untreated autologous grafts, the grafts with a pure PES mesh and
the grafts with a sirolimus-releasing PES mesh remained constant.
After 6 weeks, the relative reduction of the thickness of the intima
in the grafts wrapped with a PES mesh or with a sirolimus-releasing
PES mesh was  59 ± 12% and 73 ± 9%, respectively, in comparison to
the untreated graft. The sirolimus-releasing meshes had a signiﬁ-
cantly stronger effect reducing intimal hyperplasia than the pure
PES meshes after 6 weeks.
The increase in media thickness (Fig. 6B) was signiﬁcantly
reduced by 65 ± 9% by the use of sirolimus-releasing meshes after
3 weeks of implantation. Concurrently, a pure PES mesh did not
inﬂuence the hyperplasia of the tunica media compared to the
control untreated autologous graft, at both time intervals. After
6 weeks, the media was  signiﬁcantly thinner by 20 ± 12% in grafts
wrapped with a sirolimus releasing PES mesh than in the untreated
autologous grafts. The thickness of the intima–media complex
 mesh (B, E) and an autologous vein graft wrapped with a polyester mesh releasing
, objective 4×, scale bar = 500 m,  Olympus IX51 microscope, DP70 digital camera.
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Fig. 4. Immunohistochemical staining of CD4 in an untreated autologous graft after 3-week implantation in a rabbit (A), Pearl’s staining of iron (B) in an autologous graft
wrapped with a sirolimus-releasing PES mesh after 3-week implantation in a rabbit, and haematoxylin-eosin staining of an autologous graft wrapped with a sirolimus-
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Fig. 6C) was remarkably reduced by the sirolimus-releasing mesh
y 76 ± 5% and 37 ± 9% in comparison with the control grafts after
 and 6 weeks, respectively. At 3 weeks, a pure PES mesh reduced
hickening of the intima–media complex by 41 ± 6% compared to
he untreated autologous graft.The control autologous grafts and the sirolimus treated graft
fter 3 weeks had an intima to media ratio that was  similar to
he ratio in a healthy vein, i.e. graft 0. After 3 weeks, the sirolimus
eleasing mesh was able to keep a media/intima ratio similar to
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n  untreated autologous vein graft (graft), an autologous vein graft wrapped with a
olyester mesh (PES mesh), and an autologous vein graft wrapped with a polyester
esh releasing sirolimus (sirolimus), after 3 and 6 weeks (3w, 6w) in rabbits. The
alues are presented as mean ± SEM (standard error of mean). Two-way ANOVA
nd a Tukey pairwise comparison were used for statistical analyses. Statistical sig-
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ame number.(A, C), 200× (B) and 100× (D), Olympus BX41 microscope; CD4+ cells are stained
 graft; the foreign-body giant cells are localized around the PES mesh ﬁbres. (For
e web  version of this article.)
that of graft 0. After 6 weeks, selective thickening of the media
caused an increase in the media/intimal ratio in a graft wrapped
with sirolimus-releasing meshes, probably due to the minimal con-
centration of sirolimus in the meshes at this time interval [14]. The
highest media/intima ratio was  observed in grafts wrapped with a
pure PES mesh after 3 and 6 weeks. In these groups the ratio was
higher than the ratio of the untreated autologous graft.
4. Discussion
In the present study, we created a unique periadventitial sys-
tem with controlled release of the antiproliferative drug sirolimus
to prevent neointimal hyperplasia in the vein graft interposed to
the arterial system in rabbits. In addition, our study conﬁrmed the
hypothesis of the synergistic effects of a PES mesh and sirolimus on
vein wall remodelling.
Several experimental and clinical studies have investigated the
effects of external wall support on reducing the vessel wall stress
and inhibiting neointimal proliferation (Mehta et al., 1998). The
external torlen/dacron mesh tubing around an autologous vein
graft in sheep retarded overgrowth of both the intima and the
media within 12 weeks; the effect was  especially pronounced
in the intima (Krejca et al., 2002). The external wrap acts as a
barrier against distension of the vein graft. The polyester peri-
adventitial mesh works in the same way as the external elastic
membrane of native arterial vessels, and allows them to withstand
higher pressures in arterial circulation. It has been suggested that
haemodynamic forces, especially excessively high wall shear stress,
promote intimal hyperplasia. The wall thickness in grafts tends to
adapt to the same value as the wall thickness in the grafted artery,
which indicates that wall thickening occurs to normalize the tan-
gential wall stress (Dobrin et al., 1989). While shear stress is a
dominant regulator of lumen caliber, wall tension is a more critical
determinant of wall thickness. Animal models indicate that there is
a structurally optimal lumen radius/wall thickness ratio to support
arterial pressure with minimal wall stress (Owens, 2010).
I. Skalsky´  et al. / International Journal of Pharmaceutics 427 (2012) 311– 319 317
Fig. 6. The thickness of the intima (A), the media (B), and the intima–media complex (C) of an untreated autologous vein graft (graft), an autologous vein graft wrapped
with  a polyester mesh (PES mesh), and an autologous vein graft wrapped with a polyester mesh releasing sirolimus (sirolimus), after 3 (A–D) and 6 weeks (3w, 6w) in rabbits
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*p  ≤ 0.01 and *p ≤ 0.05 in comparison with the sample labelled with the same num
The adventitia plays an important role in the neointimal for-
ation mechanism (Shi et al., 1996; Scott et al., 1996). Mechanical
njury of the vessel induces an adventitial angiogenic response. It
as been suggested that adventitial myoﬁbroblasts play a role in
roliferation, in synthesizing growth factors and ﬁnally in migra-
ion into the neointima. Applying the antiproliferative drug from
he outer space of the vessel lumen has the advantage of hitting
he target area for administering the drug in a controlled manner.
In our study, both a PES mesh and a sirolimus-releasing PES
esh signiﬁcantly reduced intimal thickness in comparison with
he control untreated grafts 3 and 6 weeks after implantation.
etween the 3rd and 6th weeks, there was no difference in intima
hickness in all groups.
There is no convincing evidence of the durability and the
aximal effective period of external sheaths or wraps, due to
he unfavourable inﬂammatory response to the synthetic material
sed as a permanent mechanical support (Bunt, 1983). In addition,
iodegradable materials may  cease to ﬁt, and may  allow the vein
raft to expand under arterial pressure. Then the increased level of
ircumferential wall stress would not be controlled, due to the loss
f mechanical support. The mechanical support in our study was
rovided by a mesh made from polyester yarns. A yarn 90 m in
idth was formed by ﬁbres 17.5 m in diameter; the area of an indi-
idual hole in the mesh was approximately 0.44 mm2. This material
as used on the basis on the results of previously published studies
f the porosity, ﬂexibility, biocompatibility and non-inﬂammatory
esponse (Mehta et al., 1998; Hinrichs et al., 1994). Macrop-
rosity is crucial for the efﬁcacy of external stents in reducing mean). The Tukey studentized range method was used for the statistical analyses;
neointima formation in porcine vein grafts. In addition, macrop-
orous stents allow adventitial microvessels to connect with the
vasculature outside the stent, thereby potentially improving oxy-
genation. Although external stenting is highly effective in reducing
neointima formation after vein grafting, the properties of the stent
material necessary for this effect have not been deﬁned (Georgie
et al., 2001). Non-degradable wraps could elicit long-term mechan-
ical damage, especially in coronary artery bypass grafting, where
the moving heart will be directly juxtaposed to an external wrap.
New types of biodegradable wraps could provide a future option
for solving this problem.
Another important role of the external periadventitial wrap
developed in our study is in delivering sirolimus to the vein wall.
Sirolimus is used as immunosuppressant for patients with organ
transplants. This drug has been observed to inhibit IL-2 induced
T cell proliferation (Ballou and Lin, 2008). This can explain the
reduced numbers of CD4+ and CD8+ cells that we  observed in the
graft wall wrapped with a sirolimus-releasing mesh after 3 weeks
in rabbits. After 6 weeks, the difference among the groups of rab-
bits disappeared, probably due to the kinetics of sirolimus release
from the purasorb coating. In our earlier in vitro study, 67% of the
sirolimus was  released after 11 days of incubation in a phosphate-
saline buffer (Filova et al., 2011).
The counts of other cells in our grafts, such as macrophages,
plasmocytes, neutrophils and eosinophils, were very low, and
their distribution was  similar to that in normal tissues. A slightly
increased number of macrophages is associated with the presence
of foreign material, i.e. a PES mesh. The foreign-body giant
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ells correlate with tissue reaction to the presence of a PES
esh.
The presence of thrombi in all tested groups of grafts probably
esulted from the activation of blood coagulation due to damage to
he endothelium during surgery and expansion of the graft lumen
y relatively high blood pressure in the venous graft interposed
nto the arterial bed. This expansion then exposed tissues under-
ying the endothelium to the blood stream. A second reason might
e blood coagulation due to reduced blood ﬂow in the vein graft.
irolimus did not increase the incidence of thrombi in either of the
ime intervals.
Sirolimus inhibits vascular smooth muscle cell migration and
roliferation, and decreases the reocclusion of coronary arteries
ollowing angioplasty (Moses et al., 2003). There is a signiﬁcant
nhibitory effect of sirolimus on the proliferation of endothelial
ells (Liuzzo et al., 2005). Regeneration of the injured endothe-
ium after surgery depends on growth factor, such as FGF, VEGF,
DGF, and other molecules derived from endothelial cells or cir-
ulating cells. Sirolimus inhibits FGF-2 stimulated proliferation of
uman endothelial cells. Endothelium re-establishment is com-
leted in the range of weeks after extensive injury. We  observed
 conﬂuent layer of endothelial cells in the lumen of all vein grafts
fter 3 and 6 weeks. Due to the ﬁnal position of the periadventitial
rap in the tunica adventitia, smooth muscle cells in the vicinity
f the sirolimus-releasing mesh were exposed to high sirolimus
oncentrations, while distant endothelial cells were affected by
 lower sirolimus concentration. Earlier ﬁndings that there was
n increased rate of apoptosis in the graft adventitia and a lower
ate of apoptosis in the neointima after perivascular application of
luronic gel with rapamycin may  also be explained by the sirolimus
oncentration gradient (Schachner et al., 2005).
In our experiments, the vein grafts were wrapped after dilata-
ion in the arterial system. In another study (Hinrichs et al.,
994), they were wrapped before dilatation of the vein graft,
hich prevents intimal tears; however, similar results were
bserved in the thickness of the intima–media complex after 3 and
 weeks.
In rabbits, the reduction of intimal hyperplasia depended on
he sirolimus dosage in stents containing 60–200 g of sirolimus
Suzuki et al., 2001). The sirolimus concentration used in our study
as 140 g/cm2, and a maximum of 3 cm2 of PES mesh was  used
er graft. Reduced thickness of the tunica intima and also the
unica media was observed in veins wrapped with a sirolimus-
eleasing mesh after 3 and 6 weeks. The effective concentration
f sirolimus necessary for inhibiting smooth muscle cell growth
s relatively low (IC 50 = 5 ng/ml) (Owen et al., 2010), and allows a
ufﬁcient amount of the drug to be dispersed for long-term release
in the range of 4–6 weeks). The content of sirolimus in CypherTM
tents is in the range from 70 to 300 g (Venkatraman and Boey,
007). 100 or 200 g of sirolimus was applied in a pluronic gel
nto the perivascular space on a model of interposition of the infe-
ior vena cava into the common carotid artery in mice. After 1 and
 weeks, but not after 4 and 6 weeks, a signiﬁcant decrease in intima
hickness was observed only in the group with a higher sirolimus
oncentration (Schachner et al., 2004a).  Our sirolimus-releasing
esh decreased intimal hyperplasia to the non-wrapped graft by
3 ± 11% and 73 ± 9% after 3 and 6 weeks, respectively. A perivas-
ular wrap prepared from poly(-caprolactone) with rapamycin
sirolimus) reduced the thickness of the intima by 76% after 3 weeks
Pires et al., 2005). Rapamycin-eluting homogeneous ﬁlms made of
opolymer of l-lactide and -caprolactone with 8 g, 80 g, and
00 g (i.e. 1.4, 14 and 140 g/cm2; Kawatsu et al., 2007) of the
rug were applied externally to a femoral vein graft anastomosed
o the proximal femoral artery in end-to-end fashion in dogs. After
 weeks, only the highest rapamycin concentration signiﬁcantly
ttenuated intimal hyperplasia compared to the control. This washarmaceutics 427 (2012) 311– 319
accompanied by a decreased number of PCNA positive cells in the
neointima and adventitia.
The intima thickness values were almost the same in the grafts
wrapped with a sirolimus-releasing mesh after 3 and 6 weeks.
This is in agreement with the observation that maximum initial
proliferation accrual of both smooth muscle and endothelial cells
appears during the ﬁrst weeks after implantation of a vein graft
into the arterial bed. The cell proliferation returns to standard val-
ues after 12 weeks (Kalra and Miller, 2000; Zwolak et al., 1987).
According to the described time course of intimal hyperplasia, it
is probable that the intitial burst release of sirolimus during the
ﬁrst week can have a stronger protective effect against the devel-
opment of intimal hyperplasia than a stable but lower sirolimus
concentration released during the following weeks.
5. Conclusions
We  have developed a novel device with a sustained release
of sirolimus, made of a polyester mesh coated with a degradable
copolymer of l-lactide and -caprolactone loaded with sirolimus,
and we  have evaluated its effect on inhibiting intimal hyperpla-
sia in vivo in a rabbit model. After wrapping the mesh around the
autologous vein graft, sirolimus was  released into the vascular wall
through the tunica adventitia. This perivascular sirolimus-releasing
wrap signiﬁcantly decreased the thickness of the intima and pre-
vented neointimal hyperplasia of the autologous vein graft in a
rabbit model within 6 weeks.
The mechanical support of the wrapped periadventitial
polyester mesh and the antiproliferative effect of the released
sirolimus have a joint synergetic effect on preventing thickening of
the intima. Thus this system is a promising method for prolonging
the “lifetime” of the vein grafts in arterial circulation.
Both the sirolimus content in the polymer coated mesh and the
kinetics of its release seem to be favourable, since there is no intimal
hyperplasia in the rabbit model in the course of the study. In clinical
practice, this device could be effective in preventing restenosis of
autologous vein grafts.
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